Product Information
BUMETANIDE 1 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.1079 per EA under NDC 00904701604. Its NADAC has been published 332 times since May 27, 2020.
FDA first approved this application on Oct 18, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the Bumetanide market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904701604
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BUMETANIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209724FDA Approved
10/18/2017
TE Code
AB
On Market Since
10/18/2017
Pharmacological Classes
Price Statistics
The NADAC for BUMETANIDE 1 MG TABLET has been published 332 times since May 27, 2020, and over the history we have for it it has declined 72.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1079 per EA |
|---|---|
| All-time high | $0.3966 (Jun 10, 2020) |
| All-time low | $0.1075 (Aug 19, 2026) |
| 52-week high | $0.1447 |
| 52-week low | $0.1075 |
| Median price | $0.1982 |
| Average price | $0.2062 |
| Largest weekly change | +76.2% (Aug 21, 2024) |
| Weeks tracked | 332 |
| Tracking since | May 27, 2020 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Bumetanide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Loop Diuretic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BUMETANIDE 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUMETANIDE 1 MG TABLET, manufactured by Major Pharmaceuticals, is $0.1079 per EA (NDC 00904701604), effective Sep 30, 2026.
How has the price of BUMETANIDE 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUMETANIDE 1 MG TABLET has declined 72.8%. It has been tracked across 332 weekly CMS publications since May 27, 2020.
What are the highest and lowest recorded NADAC prices for BUMETANIDE 1 MG TABLET?
Since May 27, 2020, the NADAC for BUMETANIDE 1 MG TABLET has ranged from a low of $0.1075 (Aug 19, 2026) to a high of $0.3966 (Jun 10, 2020), with a median of $0.1982 per EA.
Are there cheaper alternatives to BUMETANIDE 1 MG TABLET?
10 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUMETANIDE 1 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures BUMETANIDE 1 MG TABLET?
BUMETANIDE 1 MG TABLET (NDC 00904701604) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.